![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ACSL3 |
Gene summary for ACSL3 |
![]() |
Gene information | Species | Human | Gene symbol | ACSL3 | Gene ID | 2181 |
Gene name | acyl-CoA synthetase long chain family member 3 | |
Gene Alias | ACS3 | |
Cytomap | 2q36.1 | |
Gene Type | protein-coding | GO ID | GO:0001676 | UniProtAcc | A0A024R497 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
2181 | ACSL3 | CA_HPV_1 | Human | Cervix | CC | 1.52e-02 | -1.06e-02 | 0.0264 |
2181 | ACSL3 | CCI_2 | Human | Cervix | CC | 1.29e-03 | 1.12e+00 | 0.5249 |
2181 | ACSL3 | CCI_3 | Human | Cervix | CC | 6.28e-04 | 7.30e-01 | 0.516 |
2181 | ACSL3 | HTA11_3410_2000001011 | Human | Colorectum | AD | 1.31e-13 | -5.55e-01 | 0.0155 |
2181 | ACSL3 | HTA11_696_2000001011 | Human | Colorectum | AD | 3.93e-02 | -2.33e-01 | -0.1464 |
2181 | ACSL3 | HTA11_866_3004761011 | Human | Colorectum | AD | 2.32e-08 | -4.99e-01 | 0.096 |
2181 | ACSL3 | HTA11_10711_2000001011 | Human | Colorectum | AD | 4.35e-04 | -5.11e-01 | 0.0338 |
2181 | ACSL3 | HTA11_7696_3000711011 | Human | Colorectum | AD | 2.96e-17 | -4.91e-01 | 0.0674 |
2181 | ACSL3 | HTA11_6818_2000001021 | Human | Colorectum | AD | 4.60e-03 | -5.24e-01 | 0.0588 |
2181 | ACSL3 | HTA11_99999974143_84620 | Human | Colorectum | MSS | 1.91e-16 | -4.38e-01 | 0.3005 |
2181 | ACSL3 | F007 | Human | Colorectum | FAP | 2.16e-05 | -4.56e-01 | 0.1176 |
2181 | ACSL3 | A002-C-010 | Human | Colorectum | FAP | 1.26e-07 | -3.28e-01 | 0.242 |
2181 | ACSL3 | A001-C-207 | Human | Colorectum | FAP | 3.05e-05 | -3.53e-01 | 0.1278 |
2181 | ACSL3 | A015-C-203 | Human | Colorectum | FAP | 1.84e-23 | -4.82e-01 | -0.1294 |
2181 | ACSL3 | A015-C-204 | Human | Colorectum | FAP | 8.32e-11 | -5.33e-01 | -0.0228 |
2181 | ACSL3 | A014-C-040 | Human | Colorectum | FAP | 1.01e-03 | -4.05e-01 | -0.1184 |
2181 | ACSL3 | A002-C-201 | Human | Colorectum | FAP | 9.89e-15 | -4.13e-01 | 0.0324 |
2181 | ACSL3 | A002-C-203 | Human | Colorectum | FAP | 2.06e-11 | -4.54e-01 | 0.2786 |
2181 | ACSL3 | A001-C-119 | Human | Colorectum | FAP | 1.26e-11 | -5.56e-01 | -0.1557 |
2181 | ACSL3 | A001-C-108 | Human | Colorectum | FAP | 8.30e-19 | -4.50e-01 | -0.0272 |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00092608 | Cervix | CC | ribonucleotide biosynthetic process | 37/2311 | 182/18723 | 1.44e-03 | 1.13e-02 | 37 |
GO:00068936 | Cervix | CC | Golgi to plasma membrane transport | 16/2311 | 60/18723 | 2.00e-03 | 1.46e-02 | 16 |
GO:00619516 | Cervix | CC | establishment of protein localization to plasma membrane | 16/2311 | 60/18723 | 2.00e-03 | 1.46e-02 | 16 |
GO:00430016 | Cervix | CC | Golgi to plasma membrane protein transport | 12/2311 | 40/18723 | 2.44e-03 | 1.71e-02 | 12 |
GO:00091529 | Cervix | CC | purine ribonucleotide biosynthetic process | 34/2311 | 169/18723 | 2.62e-03 | 1.81e-02 | 34 |
GO:000616310 | Cervix | CC | purine nucleotide metabolic process | 67/2311 | 396/18723 | 4.41e-03 | 2.69e-02 | 67 |
GO:007252110 | Cervix | CC | purine-containing compound metabolic process | 69/2311 | 416/18723 | 6.27e-03 | 3.54e-02 | 69 |
GO:000911710 | Cervix | CC | nucleotide metabolic process | 79/2311 | 489/18723 | 7.16e-03 | 3.85e-02 | 79 |
GO:00075846 | Cervix | CC | response to nutrient | 33/2311 | 174/18723 | 7.65e-03 | 4.07e-02 | 33 |
GO:0072659 | Colorectum | AD | protein localization to plasma membrane | 122/3918 | 284/18723 | 2.86e-17 | 1.49e-14 | 122 |
GO:0009150 | Colorectum | AD | purine ribonucleotide metabolic process | 142/3918 | 368/18723 | 4.29e-15 | 1.17e-12 | 142 |
GO:0006163 | Colorectum | AD | purine nucleotide metabolic process | 149/3918 | 396/18723 | 1.08e-14 | 2.80e-12 | 149 |
GO:0072521 | Colorectum | AD | purine-containing compound metabolic process | 153/3918 | 416/18723 | 4.34e-14 | 1.01e-11 | 153 |
GO:0009259 | Colorectum | AD | ribonucleotide metabolic process | 144/3918 | 385/18723 | 5.25e-14 | 1.13e-11 | 144 |
GO:1990778 | Colorectum | AD | protein localization to cell periphery | 129/3918 | 333/18723 | 5.51e-14 | 1.15e-11 | 129 |
GO:0019693 | Colorectum | AD | ribose phosphate metabolic process | 145/3918 | 396/18723 | 3.01e-13 | 5.71e-11 | 145 |
GO:1903829 | Colorectum | AD | positive regulation of cellular protein localization | 110/3918 | 276/18723 | 4.58e-13 | 8.44e-11 | 110 |
GO:0009117 | Colorectum | AD | nucleotide metabolic process | 168/3918 | 489/18723 | 2.20e-12 | 3.36e-10 | 168 |
GO:0006753 | Colorectum | AD | nucleoside phosphate metabolic process | 169/3918 | 497/18723 | 4.99e-12 | 6.98e-10 | 169 |
GO:0090150 | Colorectum | AD | establishment of protein localization to membrane | 100/3918 | 260/18723 | 6.01e-11 | 6.33e-09 | 100 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa00071 | Colorectum | AD | Fatty acid degradation | 20/2092 | 43/8465 | 1.50e-03 | 8.69e-03 | 5.54e-03 | 20 |
hsa000711 | Colorectum | AD | Fatty acid degradation | 20/2092 | 43/8465 | 1.50e-03 | 8.69e-03 | 5.54e-03 | 20 |
hsa047144 | Colorectum | MSS | Thermogenesis | 113/1875 | 232/8465 | 1.52e-19 | 4.62e-18 | 2.83e-18 | 113 |
hsa047145 | Colorectum | MSS | Thermogenesis | 113/1875 | 232/8465 | 1.52e-19 | 4.62e-18 | 2.83e-18 | 113 |
hsa042166 | Colorectum | CRC | Ferroptosis | 13/1091 | 41/8465 | 1.36e-03 | 1.08e-02 | 7.33e-03 | 13 |
hsa01212 | Colorectum | CRC | Fatty acid metabolism | 14/1091 | 57/8465 | 1.17e-02 | 4.99e-02 | 3.38e-02 | 14 |
hsa042167 | Colorectum | CRC | Ferroptosis | 13/1091 | 41/8465 | 1.36e-03 | 1.08e-02 | 7.33e-03 | 13 |
hsa012121 | Colorectum | CRC | Fatty acid metabolism | 14/1091 | 57/8465 | 1.17e-02 | 4.99e-02 | 3.38e-02 | 14 |
hsa04714211 | Esophagus | ESCC | Thermogenesis | 163/4205 | 232/8465 | 9.22e-11 | 1.14e-09 | 5.86e-10 | 163 |
hsa0421629 | Esophagus | ESCC | Ferroptosis | 33/4205 | 41/8465 | 4.58e-05 | 1.99e-04 | 1.02e-04 | 33 |
hsa012129 | Esophagus | ESCC | Fatty acid metabolism | 41/4205 | 57/8465 | 5.13e-04 | 1.75e-03 | 8.98e-04 | 41 |
hsa041467 | Esophagus | ESCC | Peroxisome | 55/4205 | 82/8465 | 1.04e-03 | 3.27e-03 | 1.68e-03 | 55 |
hsa04714310 | Esophagus | ESCC | Thermogenesis | 163/4205 | 232/8465 | 9.22e-11 | 1.14e-09 | 5.86e-10 | 163 |
hsa0421638 | Esophagus | ESCC | Ferroptosis | 33/4205 | 41/8465 | 4.58e-05 | 1.99e-04 | 1.02e-04 | 33 |
hsa0121214 | Esophagus | ESCC | Fatty acid metabolism | 41/4205 | 57/8465 | 5.13e-04 | 1.75e-03 | 8.98e-04 | 41 |
hsa0414612 | Esophagus | ESCC | Peroxisome | 55/4205 | 82/8465 | 1.04e-03 | 3.27e-03 | 1.68e-03 | 55 |
hsa033206 | Liver | NAFLD | PPAR signaling pathway | 25/1043 | 75/8465 | 1.61e-06 | 6.62e-05 | 5.33e-05 | 25 |
hsa012126 | Liver | NAFLD | Fatty acid metabolism | 17/1043 | 57/8465 | 3.43e-04 | 5.93e-03 | 4.78e-03 | 17 |
hsa000718 | Liver | NAFLD | Fatty acid degradation | 13/1043 | 43/8465 | 1.46e-03 | 1.71e-02 | 1.38e-02 | 13 |
hsa042168 | Liver | NAFLD | Ferroptosis | 12/1043 | 41/8465 | 2.98e-03 | 2.96e-02 | 2.39e-02 | 12 |
Page: 1 2 3 4 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
ACSL3 | SNV | Missense_Mutation | c.43N>G | p.Lys15Glu | p.K15E | O95573 | protein_coding | deleterious_low_confidence(0.04) | benign(0.114) | TCGA-AN-A0AK-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
ACSL3 | SNV | Missense_Mutation | novel | c.2009G>A | p.Ser670Asn | p.S670N | O95573 | protein_coding | tolerated(0.18) | benign(0) | TCGA-BH-A0BL-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | adriamycin | CR |
ACSL3 | insertion | Frame_Shift_Ins | novel | c.1847_1847+1insAACAAATGGAAGATGTTGGGTTTTAGAGTTTAATTTTTTTCTCA | p.Ser616ArgfsTer32 | p.S616Rfs*32 | O95573 | protein_coding | TCGA-BH-A0B8-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Hormone Therapy | arimidex | SD | ||
ACSL3 | SNV | Missense_Mutation | c.1082N>G | p.Ser361Cys | p.S361C | O95573 | protein_coding | deleterious(0) | probably_damaging(0.998) | TCGA-LP-A4AV-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD | |
ACSL3 | SNV | Missense_Mutation | rs145813997 | c.1216C>T | p.Arg406Cys | p.R406C | O95573 | protein_coding | deleterious(0) | probably_damaging(0.953) | TCGA-AA-3815-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
ACSL3 | SNV | Missense_Mutation | rs748604442 | c.689G>A | p.Arg230His | p.R230H | O95573 | protein_coding | tolerated(0.08) | benign(0.013) | TCGA-AA-3845-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD |
ACSL3 | SNV | Missense_Mutation | c.161G>A | p.Arg54Gln | p.R54Q | O95573 | protein_coding | tolerated(0.18) | benign(0.006) | TCGA-AA-3977-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
ACSL3 | SNV | Missense_Mutation | c.317G>A | p.Gly106Glu | p.G106E | O95573 | protein_coding | deleterious(0) | probably_damaging(0.991) | TCGA-AA-3984-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
ACSL3 | SNV | Missense_Mutation | c.364N>C | p.Lys122Gln | p.K122Q | O95573 | protein_coding | deleterious(0) | probably_damaging(0.973) | TCGA-AA-A010-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Chemotherapy | folinic | CR | |
ACSL3 | SNV | Missense_Mutation | c.1087N>C | p.Lys363Gln | p.K363Q | O95573 | protein_coding | deleterious(0) | possibly_damaging(0.817) | TCGA-AA-A010-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Chemotherapy | folinic | CR |
Page: 1 2 3 4 5 6 7 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |